Microvascular Rarefaction and Myocardial Fibrosis in Hypertrophic Obstructive Cardiomyopathy

被引:8
作者
Tian, Hongwei
Yang, Chengzhi
Song, Yunhu
Wang, Hongyue
Yuan, Jiansong
Cui, Jingang
Liu, Shengwen
Hu, Fenghuan
Yang, Weixian
Jiang, Xiaowei
Qiao, Shubin [1 ,2 ]
机构
[1] Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Fuwai Hosp, State Key Lab Cardiovasc Dis, 167 North Lishi Rd, Beijing, Peoples R China
[2] Peking Union Med Coll, 167 North Lishi Rd, Beijing, Peoples R China
基金
中国国家自然科学基金;
关键词
Microvascular density; Myocardial fibrosis; Hypertrophic obstructive cardiomyopathy; HEART-FAILURE; TISSUE; DYSFUNCTION; DISARRAY; COLLAGEN; YOUNG;
D O I
10.1159/000493005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Hypertrophic obstructive cardiomyopathy (HOCM) is a myocardial disease characterized by fibrosis and microvascular ischemia. Microvessels play a critical role in myocardial fibrosis in HOCM. However, it remains unclear whether or not myocardial fibrosis is associated with microvascular density (MVD) changes. Objective: The aim of the present study was to investigate whether a reduction in MVD is related to myocardial fibrosis in HOCM cardiac samples. Methods: We analyzed MVD and fibrosis in myectomy left ventricular (LV) septal wall specimens from 53 HOCM patients. Control myocardium from the LV septal wall was collected at autopsy of 9 individuals who died of noncardiac causes. Results: The fibrosis ratio (% area) in HOCM was higher and the MVD was lower than that in control subjects (i.e., 12.7 +/- 10.0 vs. 4.0 +/- 1.4%, p = 0.012, and 480.9 +/- 206.7 vs. 1,425 +/- 221/mm(2), p < 0.001). Patients with mild fibrosis had a higher MVD than patients with moderate fibrosis (i.e., 568.2 +/- 214.8 vs. 403.2 +/- 167.8/mm(2), p = 0.006) and patients with severe fibrosis (i.e., 568.2 +/- 214.8 vs. 378.6 +/- 154.0/mm(2), p =0.024). Furthermore, a significant negative correlation was found between myocardial fibrosis and MVD in HOCM patients (r = -0.40, p = 0.003), which was also found in mild fibrosis (r = -0.40, p = 0.043), moderate fibrosis (r = -0.50, p = 0.024), and severe fibrosis (r = -0.24, p = 0.61), although no significant differences were observed in severe fibrosis. Additionally, we demonstrated that late gadolinium enhancement was negatively correlated with MVD (r = -0.37, p = 0.03) and positively correlated with fibrosis (r = 0.44, p = 0.01). Conclusion: HOCM patients had a higher myocardial fibrosis ratio and a lower MVD. The severity of myocardial fibrosis was negatively correlated with MVD in HOCM. These findings showed that a reduced MVD may contribute to myocardial fibrosis in HOCM. (C) 2019 S. Karger AG, Basel
引用
收藏
页码:202 / 211
页数:10
相关论文
共 33 条
[1]   Hypertrophic cardiomyopathy and sudden death in the young: Pathologic evidence of myocardial ischemia [J].
Basso, C ;
Thiene, G ;
Corrado, D ;
Buja, G ;
Melacini, P ;
Nava, A .
HUMAN PATHOLOGY, 2000, 31 (08) :988-998
[2]   Rapid automatic assessment of microvascular density in sidestream dark field images (vol 49, pg 1269, 2011) [J].
Bezemer, Rick ;
Dobbe, Johannes G. ;
Bartels, Sebastiaan A. ;
Boerma, E. Christiaan ;
Elbers, Paul W. G. ;
Heger, Michal ;
Ince, Can .
MEDICAL & BIOLOGICAL ENGINEERING & COMPUTING, 2012, 50 (10) :1115-1115
[3]   Left Ventricular Deformation and Myocardial Fibrosis in Patients With Advanced Heart Failure Requiring Transplantation [J].
Cameli, Matteo ;
Mondillo, Sergio ;
Righini, Francesca Maria ;
Lisi, Matted ;
Dokollari, Aleksander ;
Lindqvist, Per ;
Maccherini, Massimo ;
Henein, Michael .
JOURNAL OF CARDIAC FAILURE, 2016, 22 (11) :901-907
[4]   Medical progress - Coronary microvascular dysfunction [J].
Camici, Paolo G. ;
Crea, Filippo .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (08) :830-840
[5]   IS ADIPOSE-TISSUE A NORMAL COMPONENT OF THE MYOCARDIUM [J].
CARUSO, G ;
FRASSANITO, F ;
SERIO, G ;
PENNELLA, A .
EUROPEAN HEART JOURNAL, 1989, 10 :89-91
[6]   Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy [J].
Cecchi, F ;
Olivotto, I ;
Gistri, R ;
Lorenzoni, R ;
Chiriatti, G ;
Camici, PG .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (11) :1027-1035
[7]   Microvascular Dysfunction, Myocardial Ischemia, and Progression to Heart Failure in Patients with Hypertrophic Cardiomyopathy [J].
Cecchi, Franco ;
Sgalambro, Aurelio ;
Baldi, Massimo ;
Sotgia, Barbara ;
Antoniucci, Davide ;
Camici, Paolo G. ;
Sciagra, Roberto ;
Olivotto, Iacopo .
JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH, 2009, 2 (04) :452-461
[8]   Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy [J].
Choudhury, L ;
Mahrholdt, H ;
Wagner, A ;
Choi, KM ;
Elliott, MD ;
Klocke, FJ ;
Bonow, RO ;
Judd, RM ;
Kim, RJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 40 (12) :2156-2164
[9]  
Fischer Andrew H, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.prot4986
[10]   Promoting angiogenesis protects severely hypertrophied hearts from ischemic injury [J].
Friehs, I ;
Moran, AM ;
Stamm, C ;
Choi, YH ;
Cowan, DB ;
McGowan, FX ;
del Nido, PJ .
ANNALS OF THORACIC SURGERY, 2004, 77 (06) :2004-2011